Eur J Clin Nutr. 1999 Nov;53(11):891-4.
Saturday, 31 October 2015
Cowin 1999
Oboh 1998
J Chromatogr A. 1998 Oct 9;823(1-2):307-12.
Anti-nutritional constituents of six underutilized legumes grown in Nigeria.
Abstract
Martínez-Villaluenga 2005
J Food Prot. 2005 Jun;68(6):1246-52.
Raffinose family of oligosaccharides from lupin seeds as prebiotics: application in dairy products.
Abstract
Giannoccaro 2008
Comparison of two HPLC systems and an enzymatic method for quantification of soybean sugars.
Successful breeding programs need fast and reliable methods for analyzing sugar composition in new soybean (Glycine max (L.) Merrill) lines. The efficiency to quantify the major sugars, including glucose, fructose, sucrose, raffinose, and stachyose, in fivesoybean lines with two HPLC systems and an enzymatic procedure were compared. Soluble sugars in soybean were extracted with water at a solvent-to-sample ratio of 5:1 at 50°C for 15min, and analyzed by high-performance size exclusion chromatography with refractive index detection (HPSEC-RI), high-performance anion-exchange chromatography with pulsed-amperometric detection (HPAEC-PAD), and a raffinose-series oligosaccharides assay procedure. All three methods produced comparable and reproducible results. The HPAEC-PAD method was more sensitive, faster and capable of separating all five major sugars in soybean with improved peak resolution compared with the HPSEC-RI method, and is recommended for soybeanbreeding programs. The enzymatic procedure required no expensive instrumentation and less sample preparation, but could not quantify individual raffinose and stachyose.
Richmond 1981
Analysis of simple sugars and sorbitol in fruit by high-performance liquid chromatography
Michael L. Richmond; Sebastiao C. C. Brandao; J. Ian Gray; Pericles Markakis; Charles M. Stine
Journal of Agricultural and Food Chemistry. 1981;29(1):4-7.
Abstract
The application of a high-performance liquid chromatographic (LC) procedure for the determination of sugars and sorbitol in fresh fruits is described. This system combines the use of two bonded phase carbohydrate columns, joined in tandem; a ternary mobile phase (acetonitrile-water-ethanol) and a differential refractometer to accurately and precisely separate fructose, glucose, sorbitol, sucrose, and maltose. Total analysis time was 20 min for the five-sugar mixture. Twenty-four fruits were analyzed including eleven from the family Rosaceae, which often contain sorbitol. Sample recoveries ranged from 98% for fructose to 102% for maltose. © 1981 American Chemical Society.
Andersson 2009
J Agric Food Chem. 2009 Mar 11;57(5):2004-8. doi: 10.1021/jf801280f.
Content and molecular-weight distribution of dietary fiber components in whole-grain rye flour and bread.
Abstract
Sreenath 2008
Anal Bioanal Chem. 2008 May;391(2):609-15. doi: 10.1007/s00216-008-2016-x. Epub 2008 Mar 28.
Analysis of erythritol in foods by polyclonal antibody-based indirect competitive ELISA.
Sreenath K1, Venkatesh YP.Abstract
Sugar alcohols are widely used as food additives and drug excipients. Erythritol (INS 968) is an important four-carbon sugar alcohol in the food industry. Erythritol occurs naturally in certain fruits, vegetables, and fermented foods. Currently, HPLC and GC methods are in use for the quantification of erythritol in natural/processed foods. However, an immunoassay for erythritol has not been developed so far. We have utilized affinity-purified erythritol-specific antibodies generated earlier [9] to develop an indirect competitive ELISA. With erythritol–BSA conjugate (54 mol/mol; 100 ng/well) as the coating antigen, a calibration curve was prepared using known amounts of standard meso-erythritol (0.1–100,000 ng) in the immunoassay. Watermelon (Citrullus lanatus) and red wine were selected as the food sources containing meso-erythritol. The amount of meso-erythritol was calculated as 2.36 mg/100 g fresh weight of watermelon and 206.7 mg/L of red wine. The results obtained from the immunoassay are in close agreement with the reported values analyzed by HPLC and GC (22–24 mg/kg in watermelon and 130–300 mg/L in red wine). The recovery analyses showed that added amounts of meso-erythritol were recovered fairly accurately with recoveries of 86–105% (watermelon) and 85–93.3% (red wine). The method described here for erythritol is the first report of an immunoassay for a sugar alcohol.
Akin 2008
Some compositional properties of main Malatya apricot (Prunus armeniaca L.) varieties.
Department of Food Engineering, Hacettepe University, 06800 Beytepe, Ankara, Turkey
Food Chemistry (Impact Factor: 3.39). 03/2008; 116(2):939-948. DOI: 10.1016/j.foodchem.2007.08.052
ABSTRACT
Malatya apricot (Prunus armeniaca L.) varieties are among the most important agricultural products of Turkey and protected as a geographical indication. In this research, it was aimed to determine some important analytical properties (dry matter, soluble solid content, aw, ash, titratable acidity, pH, color, total phenolics, total carotenoids, β-carotene, sugars, organic acids, and mineral content) of Malatya apricots and to reveal the characteristic properties that differ these products from the similar ones. The apricot varieties, namely Hacıhaliloğlu, Hasanbey, Soğancı, Kabaaşı, Çataloğlu, Çöloğlu, and Hacıkız that are widely cultivated in Malatya region and other regions (Ereğli, İzmir, Iğdır, and Bursa) of Turkey were involved in the study. All analytical properties were found to be significantly different (p < 0.05) among different apricot varieties. The results have shown that dry matter and sugar content of Malatya apricot varieties are considerably higher than the other apricot varieties investigated in this study, as well as the data of other researches on apricots. All apricot varieties were found to be a good source of phenolic compounds (4233.70–8180.49 mg of gallic acid equiv/100 g of dry weight), carotenoids (14.83–91.89 mg of β-carotene equiv/100 g of dry weight), and β-carotene (5.74–48.69 mg/100 g of dry weight). Sucrose, glucose, and fructose were determined as the major sugars in all apricot varieties. In addition, sorbitol contents (16.91–26.84 mg/100 g of dry weight) of Malatya apricots were remarkably higher than the other apricot varieties. This was considered to be the one of the unique properties of Malatya apricots. Malic acid was the predominant organic acid in all Malatya apricot varieties. The results have also shown that the potassium content of Malatya apricots was significantly high and these apricots were important sources of Mg, Zn, and Se. This study has revealed that Malatya apricot contains functional food components with high nutritional value.
Some compositional properties of main Malatya apricot (Prunus armeniaca L.) varieties - ResearchGate. Available from: http://www.researchgate.net/publication/223101227_Some_compositional_properties_of_main_Malatya_apricot_(Prunus_armeniaca_L.)_varieties [accessed Oct 31, 2015].
L'homme C 2001 abstract
J Chromatogr A. 2001 Jun 22;920(1-2):291-7.
Evaluation of fructans in various fresh and stewed fruits by high-performance anion-exchange chromatography with pulsed amperometric detection.
Abstract
Fodmap Links
A FODMAP Diet Update: Craze or Credible?
http://www.medicine.virginia.edu/clinical/departments/medicine/divisions/digestive-health/nutrition-support-team/nutrition-articles/Parrish_Dec_12.pdf
Heidi M. Staudacher. Fermentable Carbohydrate Restriction Reduces Luminal Bifidobacteria and Gastrointestinal Symptoms in Patients with Irritable Bowel Syndrome http://jn.nutrition.org/content/142/8/1510.full
van Loo J. On the presence of inulin and oligofructose as natural ingredients in the western diet. http://www.ncbi.nlm.nih.gov/pubmed/8777017
M. C. E. Lomer. Review article: the aetiology, diagnosis, mechanisms and clinical evidence for food intolerance. http://onlinelibrary.wiley.com/doi/10.1111/apt.13041/abstract
Jacqueline S. Barrett. Extending Our Knowledge of Fermentable, Short-Chain Carbohydrates for Managing Gastrointestinal Symptoms. http://www.clinicaleducation.org/documents/NutrClin-Pract-2013-Barrett-0884533613485790.pdf
Peter R Gibson. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. http://onlinelibrary.wiley.com/doi/10.1111/j.1440-1746.2009.06149.x/abstract
M. C. E. LOMER. Review article: lactose intolerance in clinical practice – myths and realities. http://onlinelibrary.wiley.com/store/10.1111/j.1365-2036.2007.03557.x/asset/j.1365-2036.2007.03557.x.pdf?v=1&t=igfff2hl&s=054ddf83b5c76dd94fcc52755d6541cb8fcbc701
Bernadette P. Marriott. National Estimates of Dietary Fructose Intake Increased from 1977 to 2004 in the United States. http://jn.nutrition.org/content/139/6/1228S
P. R. Gibson. Functional bowel symptoms and diet. http://onlinelibrary.wiley.com/doi/10.1111/imj.12266/abstract
C. K. Yao. Dietary sorbitol and mannitol: food content and distinct absorption patterns between healthy individuals and patients with irritable bowel syndrome. http://onlinelibrary.wiley.com/doi/10.1111/jhn.12144/abstract
Heidi M. Staudacher. Mechanisms and efficacy of dietary FODMAP restriction in IBS. http://www.nature.com/nrgastro/journal/v11/n4/full/nrgastro.2013.259.html
Emma P. Halmos. A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome. http://www.gastrojournal.org/article/S0016-5085(13)01407-8/abstract?referrer=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpubmed%2F24076059
Jane G. Muir. Fructan and Free Fructose Content of Common Australian Vegetables and Fruit.
Extra:
Kathy R. Niness. Inulin and Oligofructose: What Are They? http://jn.nutrition.org/content/129/7/1402S.full
Heidi M. Staudacher. Fermentable Carbohydrate Restriction Reduces Luminal Bifidobacteria and Gastrointestinal Symptoms in Patients with Irritable Bowel Syndrome http://jn.nutrition.org/content/142/8/1510.full
van Loo J. On the presence of inulin and oligofructose as natural ingredients in the western diet. http://www.ncbi.nlm.nih.gov/pubmed/8777017
M. C. E. Lomer. Review article: the aetiology, diagnosis, mechanisms and clinical evidence for food intolerance. http://onlinelibrary.wiley.com/doi/10.1111/apt.13041/abstract
Jacqueline S. Barrett. Extending Our Knowledge of Fermentable, Short-Chain Carbohydrates for Managing Gastrointestinal Symptoms. http://www.clinicaleducation.org/documents/NutrClin-Pract-2013-Barrett-0884533613485790.pdf
Peter R Gibson. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. http://onlinelibrary.wiley.com/doi/10.1111/j.1440-1746.2009.06149.x/abstract
M. C. E. LOMER. Review article: lactose intolerance in clinical practice – myths and realities. http://onlinelibrary.wiley.com/store/10.1111/j.1365-2036.2007.03557.x/asset/j.1365-2036.2007.03557.x.pdf?v=1&t=igfff2hl&s=054ddf83b5c76dd94fcc52755d6541cb8fcbc701
Bernadette P. Marriott. National Estimates of Dietary Fructose Intake Increased from 1977 to 2004 in the United States. http://jn.nutrition.org/content/139/6/1228S
P. R. Gibson. Functional bowel symptoms and diet. http://onlinelibrary.wiley.com/doi/10.1111/imj.12266/abstract
C. K. Yao. Dietary sorbitol and mannitol: food content and distinct absorption patterns between healthy individuals and patients with irritable bowel syndrome. http://onlinelibrary.wiley.com/doi/10.1111/jhn.12144/abstract
Heidi M. Staudacher. Mechanisms and efficacy of dietary FODMAP restriction in IBS. http://www.nature.com/nrgastro/journal/v11/n4/full/nrgastro.2013.259.html
Emma P. Halmos. A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome. http://www.gastrojournal.org/article/S0016-5085(13)01407-8/abstract?referrer=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpubmed%2F24076059
Jane G. Muir. Fructan and Free Fructose Content of Common Australian Vegetables and Fruit.
Extra:
Kathy R. Niness. Inulin and Oligofructose: What Are They? http://jn.nutrition.org/content/129/7/1402S.full
Tuesday, 20 October 2015
Hostgator chat
Jeffrey E
Welcome to LiveChat. My name is Jeffrey and I will be glad to assist you with this.
Katusha
Hi)
Katusha
I have a hosting on Hostgator and one site. I would like to set up another blog. Can I do this on the existing hosting?
Jeffrey E
Let me check on the hosting package. Thank you for your patience.
Jeffrey E
Yes, you can host multiple websites on your domain. All you would need to do is purchase the domain and then set the nameservers at the domain registrar to 1st Nameserver: ns6475.hostgator.com 2nd Nameserver: ns6476.hostgator.com . Then you would create the addon domain in cpanel. In order to see the domain in cpanel, you will need to create an addon domain. Here is a guide that will walk you through the steps to create an addon domain: support.hostgator.com/articles/cpanel/how-do-i-create-and-remove-an-addon-domain
Katusha
Will the new site be associated with an old one in any way?
Jeffrey E
No, when you create the addon domain it creates a subdirectory where the new site is installed. It will be its own site.
Katusha
Is there a guide of how to "set the nameservers at the domain registrar to 1st Nameserver:ns6475.hostgator.com 2nd Nameserver: ns6476.hostgator.co?" . I am not good with this stuff.
Jeffrey E
That are the nameservers you set at the domain registrar. Where did you register the new domain? If you have not registered the new domain you can do so here register.hostgator.com
Katusha
meaning I can buy the domain at register.hostgator.com? Or I need to buy it elsewhere and register atregister.hostgator.com.
Jeffrey E
You can buy the domain at register.hostgator.com or you can purchase elsewhere. Those nameservers I listed are the ones you want to set when you purchase the domain so it maps the domain to your hostgator server .
Katusha
Once it is registered, I can then set up a new wordpress site under those nameservers?
Jeffrey E
Yes, you can install wordpress using quickinstall inside cpanel. support.hostgator.com/articles/specialized-help/technical/wordpress/how-to-install-wordpress . That is done after you create the addon domain in cpanel.
Katusha
Which one do I use for the new domain: 6475.hostgator.com or ns6476.hostgator.com? Either?
Jeffrey E
You use both . Here is a guide on how to do that if you register at hostgator.support.hostgator.com/articles/hosting-guide/lets-get-started/domain-names-buy-sell-manage/changing-name-servers-with-launchpad
Katusha
Great! Thank you for your help. I will try to do this. Do you have any recommendations on where to buy a wp template so it is responsive to mobile devices?
Jeffrey E
You're welcome. While I do not have a recommendation for a wordpress template for mobile site design we do offer GoMobi as an addon service to your account that will help with the design of a mobile site. Here is more information on GoMobi support.hostgator.com/articles/hosting-guide/publish-your-site/gomobi/about-gomobi
Katusha
This is for creating a mobile site, most probably not ideal for a desktop site?
Katusha
Or can you adopt an existing desktop site to look different on the mobile?
Jeffrey E
It is in addition to a desktop site you design using wordpress. It will redirect traffic to the mobile site if they are using a mobile device but you would still have a normal desktop site built by wordpress.
FODMAP Diet basics
Carbohydrate Absorption
Carbohydrate absorption takes place in the small intestine.
Here the carbohydrates undergo hydrolysis by luminal
and brush border hydrolyses to monosaccharides:
glucose, galactose, and fructose.
These molecules are
A FODMAP Diet Update then transported across the epithelium. There are 3 main
transporters involved in this process:
- SGLT1 is the sodium/glucose-galactose co-transporter that is present in the apical membrane of the small intestinal epithelium. When luminal concentrations of glucose are low, SGLT1 can transport glucose and galactose against a concentration gradient.
- GLUT5 is a facultative transporter that is specific to fructose. This transporter is found in the apical membrane along the length of the small intestine.
- GLUT2 is a low affinity facultative transporter that will carry glucose, fructose, and galactose.8 Unlike GLUT5, GLUT2 is present on the basolateral membrane and it transports hexoses down a concentration gradient out of the cell. This transporter is inserted into the apical membrane when SGLT1 transports glucose. It allows for a high capacity, low affinity pathway for absorption of glucose, galactose, and fructose. The glucose uptake with this transporter activates a system that can efficiently take up all hexoses. This is a diffusional pathway that explains why fructose uptake is increased by glucose and sucrose. This mechanism appears to be highly adaptive to wide variations of luminal glucose concentrations and ensures maximal nutrient utilisation proximally in order to protect distal regions of the intestine from the presence of hexoses.
Symptoms of FGID can result from the
malabsorption of fructose and sucrose that occurs when
the activity of one of these transporters is altered. As
stated above, fructose absorption is highly dependent
on GLUT 5 activity, and GLUT 5 expression appears
to be influenced by dietary fructose and sucrose
load. GLUT 2 expression can be inhibited by stress,
glucocorticosteroids, or a diet with a low glycemic
index. When the small intestine is unable to absorb
fructose, it is transported into the large intestine where
it is fermented by colonic flora. During fermentation,
hydrogen, carbon dioxide, short-chain fatty acids, and
other trace gases are produced, which are thought to lead
to symptoms of bloating. The delivery of fructose to
the distal small bowel and colon also exerts an osmotic
effect causing an increased resorption of water from
the gut mucosa into the lumen. This increased water
accelerates gut motility, and can cause the symptom
of diarrhoea.
Oligosaccharides
An oligosaccharide is simply a carbohydrate whose
molecules are composed of a relatively small number
of monosaccharide units. For example, chains of
fructose with one glucose molecule on the end are
oligosaccharides known as fructans. The small intestine
lacks hydrolase capable of breaking fructose-fructose
bonds; therefore, fructans are not transported across
the epithelium or absorbed at all. Studies have shown
that 50-90% of ingested fructans can be recovered from
stool output of patients with an ileostomy. Wheat is
a major source of fructans in the diet, which means
most breads, pasta, and pastries contain large amounts
of fructans. Other sources are vegetables
such as onions, garlic, and artichokes. Galactans are
chains of galactose with one fructose molecule on the
end and act similarly to fructans. Foods rich in galactans
are legumes (soy, beans, chickpeas, lentils), cabbage,
and brussels sprouts.
Disaccharides and Monosaccharides
Fructose exists as a monosaccharide (free fructose)
or a disaccharide (sucrose). Fructose is absorbed
directly from the small intestine. When ingested as
sucrose the molecule is cleaved to one glucose unit and
one fructose unit by sucrase, which is then absorbed
into the bloodstream. The capacity at which fructose
is absorbed ranges from about 15-50g per day with
greatest absorption occurring when glucose and
fructose are administered in equal quantities. This is
because fructose exists with glucose in a 1:1 ratio. The facultative transporter GLUT5 is present throughout the small intestine and takes up free fructose. When present with glucose, fructose is taken up more efficiently due to the insertion of GLUT-2 into the apical membrane of the enterocyte. Therefore malabsorption of fructose occurs when fructose is present in excess of glucose. Some foods rich in fructose are honey, prunes, dates, apples, pears, and papaya. It is also often added to commercial foods and drinks as high fructose corn syrup. Disaccharides such as lactose are found in dairy products, but may also be found in most beers or prepared soups and sauces.
Sorbitol is the most common polyol in the diet. Unlike some others in the FODMAP group, the absorption of polyols are not accelerated by co-ingestion with glucose. A few studies have found that sorbitol and fructose ingested together cause worsening IBS symptoms. Most artificial sweetners contain polyols such as mannitol, xylitol, or sorbitol. Interestingly, symptoms from polyols not only come from foods, but also other ingested substances such as toothpastes, mints, sugar-free chewing gum, and many liquid cough/cold and pain relief preparations. Patients with small bowel bacterial overgrowth appear to be even more sensitive to polyol containing foods.
Before examining the evidence, it is important to understand that high level, large study evidence in support of therapeutic dietary intervention is hard to come by because of the complexity of the diet and the difficulty in making changes to ones dietary routine. Dietary studies cannot be compared with the same objectives used in analyzing pharmacologic therapy. In the last few years there have been more studies supporting the ideas behind the FODMAP diet, as well as evaluating carbohydrate malabsorption and its clinical role in the symptoms of FGID. Early studies of dietary therapy in FGID seemed to focus mainly on fructose restriction or lactose restriction rather than global FODMAP restriction. A pilot study then showed a low FODMAP diet led to sustained improvement in all gut symptoms in 77% of 62 patients with IBS and fructose malabsorption. There were no placebo-controlled trials evaluating this subject until 2008. At that time Shepherd et al studied 25 patients with IBS in a double-blinded, randomized, quadruple arm, placebo-controlled rechallenge trial.16 The aim of this study was to determine whether dietary restriction was the likely mechanism for symptomatic benefit as well as to define whether the efficacy resided in the restriction of free fructose specifically, or whether it reflected a restriction of poorly absorbed, shortchain carbohydrates in general. The study used test substances (fructose, fructans, glucose) in different phases on patients who were already on a diet low in FODMAPS. Seventy-seven percent of patients who received fructose and fructans and 79% receiving a mixture of fructose, fructans, and glucose reported their symptoms were not adequately controlled; however, only 14% of patients who received just glucose reported that symptoms were not controlled low FODMAP diet in patients with IBS. Most recently, Staudacher and colleagues evaluated 82 patients who attended a follow up dietetic outpatient visit for IBS symptoms.19 They found that more patients in the low FODMAP group reported satisfaction with their symptom response to the diet compared to the standard group. Statistically significant symptomatic improvement was seen with respect to bloating, abdominal pain, and flatulence.
The low FODMAP diet will benefit most patients with FGID. One study showed improvement of symptoms in 75% of patients. The majority of patients with functional GI disorders complain that certain foods make their symptoms worse. A combined approach is likely to yield the greatest treatment success and improvement in symptoms. This article has focused on the use of the FODMAP diet in treating patients with FGID but there is also evidence that a low FODMAP diet may help symptoms in patients with IBD. Other studies have been done using the FODMAP diet on patients with an ileostomy or ileal pouch to decrease high output. Initial research is promising but more studies are needed in both of these areas before the diet will be routinely recommended for those conditions. Recent research has also linked enteral nutrition–associated diarrhoea to the FODMAP content of the enteral formula; therefore, some patients may benefit from low FODMAP enteral nutrition. Researchers at Monash University found that the liquid nutritional supplements are 3-7 times more concentrated in FODMAPs than an average Australian diet and this cannot be predicted by ingredient lists. Also reviewing enteral nutrition, an earlier study from the same institution retrospectively studied 160 patients to determine the source of developing diarrhea in hospitalized patients. The patient’s length of stay and enteral nutrition duration were found to be independent predictors of developing diarrhea. Interestingly, starting an enteral nutrition formula with the lowest FODMAP content seemed to decrease the likelihood of diarrhea and this was statistically significant.
The short answer to this question is easy, with a dietician’s assistance. It is the physician’s responsibility to accurately diagnose the patient with a FGID, order breath tests if available, and investigate any alarm symptoms that may be present. It is essential for primary care physicians and gastroenterologists to understand the science behind FODMAPS, carbohydrate digestion, and the role of the FODMAP diet; however, in clinical practice today, especially in the primary care setting, most physicians are unable to dedicate 20 to 30 minutes to educate patients regarding their nutrition needs, Teaming up with a local nutritionist is the key to treating these patients. Physicians must start the process, but specific education will be done in detail at the nutritionist visit. In general, the following approach, suggested by Dr. Gibson, can be implemented in initiating this diet:
The above evidence indicates that the FODMAP diet provides an effective approach to managing patients with FGID. Drug therapy is often necessary as well, but long-term success is likely to take place only after the addition of dietary changes. More research is needed to determine the FODMAP content of all foods and to determine the legitimacy of applying a low FODMAP diet to patients with IBD. Many gastroenterologist and dietitians are now starting to apply this diet in clinical practice. The FODMAP diet may have once been a craze, but now with an increasing body of evidence behind it, is definitely a credible and valuable tool in the management of patients with FGID.
Polyols
Evidence Behind the Diet
Patient Populations Benefitting from a Low FODMAP Diet
How Should the FODMAP Diet be Used?
- Hydrogen breath testing if readily available as this could potentially limit what foods need to be restricted.
- Referral to a dietitian who is comfortable with the low FODMAP approach for examination of the patient’s current diet to determine potential triggers, education regarding malabsorption, and education regarding portion control of fructose containing foods.
- Complete FODMAP restriction for 6 weeks. This is an important concept behind the diet, understanding that an initial global restriction is indicated rather than avoiding only fructose or lactose containing foods.
- A slow controlled reintroduction of FODMAPs to determine the level that will be tolerated.
CONCLUSION
The above evidence indicates that the FODMAP diet provides an effective approach to managing patients with FGID. Drug therapy is often necessary as well, but long-term success is likely to take place only after the addition of dietary changes. More research is needed to determine the FODMAP content of all foods and to determine the legitimacy of applying a low FODMAP diet to patients with IBD. Many gastroenterologist and dietitians are now starting to apply this diet in clinical practice. The FODMAP diet may have once been a craze, but now with an increasing body of evidence behind it, is definitely a credible and valuable tool in the management of patients with FGID.
References
1. Drossman, DA. The
functional gastrointestinal disorders and the Rome II process. Gut
1999;45(suppl 2):1-5.
2. Nanda, R, James,
R, Smith H et al. Food intolerance and the irritable bowel syndrome. Gut
1989;30:1099-104.
3. Bentley, SJ,
Pearson, DJ, Rix KJ. Food hypersensitivity in irritable bowel syndrome. Lancet
1983;2:295-7.
4. Gibson, PR,
Newnham, E, Barrett JS, et al. Review article: fructose malabsorption and the
bigger picture. Aliment. Pharmacol There. 2007;25:349-63.
5. Nussey, S,
Whitehead, S. Endocrinology: An Integrated Approach. Oxford: BIOS Scientific
Publishers; 2001. Box 2.3. Absorption of monosaccharides in the small
intestine.
6. Ferraris, RP.
Dietary and developmental regulation of intestinal sugar transport. Biochem J.
2001;360:265-6.
7. Pessin, JE, Bell
GI. Mammalian facilitative glucose transporter family: structure and molecular
regulation. Annu Rev Physiol. 1992;54:911-30.
8. Thorens, B, Cheng,
ZQ, Brown D. et al. Liver glucose transporter: a basolateral protein in
hepatocytes and intestine and kidney cells. Am J Physiol. 1990;259:C279-85.
9. Cheeseman CI.
Intestinal hexose absorption: transcellular or paracellular fluxes. J Physiol.
2002;544:336.
10. Castello, A,
Guma, A, Sevilla L, et al. Regulation of GLUT5 gene expression in rate
intestinal mucosa: regional distribution, circadian rhythm, perinatal
development and effect of diabetes. Biochem J. 1995;309:271-7.
11. Croagh, C,
Shepherd SJ, et al. Pilot study on the effect of reducing dietary FODMAP intake
on bowel function in patients without a colon. Inflammatory Bowel Diseases
2007;13(12):1522-8.
12. Gibson, PR,
Shepherd SJ. Evidence-based dietary management of functional gastrointestinal
symptoms: The FODMAP approach. Journal of Gastroenterology & Hepatology
2010;25(2):252-8.
13. Choi, YK, Johlin,
FC, Summers RW et al. Fructose intolerance: an under recognized problem. Am J
Gastroenterol. 2003;98:1348-1353.
14. Symons, P, Jones,
MP, Kellow JE. Symptoms provocation in irritable bowel syndrome. Effects of
differing doses of fructosesorbitol. Scan J Gastroenterol. 1992;27:940-944.
15. Shepherd, SJ,
Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome:
guidelines for effective dietary management. J. Am. Diet. Assoc.
2006;106:1631-9.
16. Shepherd, SJ,
Parker, FC, Muir JG et al. Dietary triggers of abdominal symptoms in patients
with irritable bowel syndrome: randomized placebo controlled evidence. Clin.
Gastroenterol. Hepatol 2008;6:765-71.
17. Barrett, JS,
Gearry, RB, Muir JG et al. Dietary poorly absorbed, short-chain carbohydrates
increase delivery of water and fermentable substrates to the proximal colon.
Aliment. Pharmacol. There. 2010;31:874-82.
18. Ong, DK,
Mitchell, SB, Barrett JS et al. Manipulation of dietary short chain
carbohydrates alters the pattern of gas production and genesis of symptoms in
irritable bowel syndrome. J. Gastroenterol. Hepatol. 2010;25:1366-72.
19. Staudacher, HM,
Whelan, K, Irving PM et al. Comparison of symptom response following advice for
a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary
advice in patients with irritable bowel syndrome. Journal of Human Nutrition
& Dietetics 2011;24(5):487-95.
20. Barrett, JS,
Irving, PM, Shepherd SJ et al. Comparison of the prevalence of fructose and
lactose malabsorption across chronic intestinal disorders. Aliment. Pharmacol
There. 2009;30:165-74.
21. Gearry, RB,
Irving, PM, Barrett JS et al. Reduction of dietary poorly absorbed short-chain
carbohydrates (FODMAPS) improves abdominal symptoms in patients with
inflammatory bowel disease- a pilot study. J. Crohns Colitis 2009;3:8-14.
22. Gibson, PR,
Shepherd SJ. Personal view: food for thought- -western lifestyle and
susceptibility to Crohn’s disease. The FODMAP hypothesis. Aliment Pharmacol
& Therap. 2005;21(12):1399-409.
23. Halmos, EP,
Liels, KL, Rosella O. Enteral and oral nutritional supplement formulas deliver
laxative doses of FODMAPs which cannot be predicted by ingredients lists.
Journal of Gastroenterology and Hepatology 2011;26(suppl 4):73.
24. Halmos, EP, Muir,
JG, Barrett JS et al. Diarrhoea during enteral nutrition is predicted by the
poorly absorbed short-chain carbohydrate (FODMAP) content of the formula.
Aliment Pharmacol Ther. 2010;32(7):925-933.
25. Gibson, PR. Food
intolerance in functional bowel disorders. Journal of Gastroenterology &
Hepatology 2011;26(suppl 3):128-31.
Subscribe to:
Comments (Atom)